Prostate cancer Cancer Malignant neoplasm of prostate
Conditions
Interventions
The study was an RCT of treatment preceded by case-finding in the community, with qualitative research methods integrated at each stage. Men with confirmed localised prostate cancer were asked to cons
Sponsors
Department of Health (UK)
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Men aged 50-69 years from specific primary care centres in the three cities were invited to attend a 30-minute prostate check clinic appointment in which they were informed about the study and asked to consent to a prostate specific antigen (PSA) test. Men with a raised PSA (initially =3.0 ng/ml if 50?59 years; =4.0 ng/ml if 60?69 years; but changed to =3.0 ng/ml for all men after 1 year) were invited for biopsy. Men with confirmed localised prostate cancer were invited to participate in a randomised trial of recruitment strategies.
Exclusion criteria
Exclusion criteria: Men considered by the GP to be unfit for any of the potential treatments (ie those terminally ill or with serious co-morbidity).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome was the proportion of patients accepting randomisation to the treatment trial. Number of eligible patients randomised by nurses and urologists | — |
Secondary
| Measure | Time frame |
|---|---|
| Cost effectiveness of nurses and urologists | — |
Countries
United Kingdom
Outcome results
None listed